중증천식의 진단
Diagnosis of Severe Asthma: Definition and Identification
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Severe asthma is associated with substantial morbidity, use of healthcare resources, and long-term sequelae including declining lung function and frequent exacerbations. The identification of severe asthma is challenging due to the heterogeneity of the disease, the complexity of diagnosis, and the impact of comorbidities. A structured approach to the assessment of severe asthma may be helpful to the practicing clinician. First, it is important to confirm a diagnosis of asthma. The lack of a response to treatment or the requirement for high doses of medication to control symptoms are signs of disease mimickers, comorbidities, or the influence of environmental factors. Second, medication adherence and the inhaler technique should be checked in advance. Third, the phenotypic characteristics of patients confirmed to have severe asthma can indicate the therapies likely to be most effective. Further research that seeks to define the phenotypes of severe asthma based on endotype will enable the development of novel and effective therapeutic options for patients with severe asthma.
Abstract
Severe asthma is associated with substantial morbidity, use of healthcare resources, and long-term sequelae including declining lung function and frequent exacerbations. The identification of severe asthma is challenging due to the heterogeneity of the disease, the complexity of diagnosis, and the impact of comorbidities. A structured approach to the assessment of severe asthma may be helpful to the practicing clinician. First, it is important to confirm a diagnosis of asthma. The lack of a response to treatment or the requirement for high doses of medication to control symptoms are signs of disease mimickers, comorbidities, or the influence of environmental factors. Second, medication adherence and the inhaler technique should be checked in advance. Third, the phenotypic characteristics of patients confirmed to have severe asthma can indicate the therapies likely to be most effective. Further research that seeks to define the phenotypes of severe asthma based on endotype will enable the development of novel and effective therapeutic options for patients with severe asthma.
참고문헌 (10)
- "Korean guideline for asthma" (2018)[URL]
- "Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society", Am J Respir Crit Care Med, 162, pp.2341~2351 (2000)[DOI]
- Ivanova JI, "Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma", J Allergy Clin Immunol, 129, pp.1229~1235 (2012)[DOI]
- Chung KF, "International ERS", ATS guidelines on definition, evaluation and treatment of severe asthma, 2014, pp.43, 343~373
- Bousquet J, "Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma", J Allergy Clin Immunol, 126, pp.926~938 (2010)[DOI]
- Robinson DS, "Systematic assessment of difficult-to-treat asthma", Eur Respir J, 22, pp.478~483 (2003)[DOI]
- Sulaiman I, "A randomised clinical trial of feedback on inhaler adherence and technique in patients with severe uncontrolled asthma", Eur Respir J, 51, pp.1701126~ (2018)[DOI]
- Price D, "Establishing the relationship of inhaler satisfaction, treatment adherence, and patient outcomes: a prospective, real-world, cross-sectional survey of US adult asthma patients and physicians", World Allergy Organ J, 8, pp.26~ (2015)[DOI]
- Ledford DK, "Asthma and comorbidities", Curr Opin Allergy Clin Immunol, 13, pp.78~86 (2013)[DOI]
- Choi S, "Quantitative computed tomographic imaging-based clustering differentiates asthmatic subgroups with distinctive clinical phenotypes", J Allergy Clin Immunol, 140, pp.690~700 (2017)[DOI]